The cocultured cells were treated with anti-human IL-17A neutralizing antibodies or human IgG1 (IgG1) for 24 h, and the proliferation and apoptosis activity of the leukemia cells were then evaluated (Fig. 2a). The gene discussed is IL17A; the disease is leukemia.